TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bio-Nord AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,627
|
1,500
|
1,204 |
| Financial expenses |
62
|
105
|
25 |
| Earnings before taxes |
-31
|
90
|
7 |
| EBITDA |
31
|
196
|
31 |
| Total assets |
2,134
|
996
|
1,869 |
| Current assets |
2,134
|
996
|
1,869 |
| Current liabilities |
2,030
|
857
|
1,782 |
| Equity capital |
72
|
110
|
61 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
3.4%
|
11.0%
|
3.3% |
| Turnover per employee |
542
|
500
|
401 |
| Profit as a percentage of turnover |
-1.9%
|
6.0%
|
0.6% |
| Return on assets (ROA) |
1.5%
|
19.6%
|
1.7% |
| Current ratio |
105.1%
|
116.2%
|
104.9% |
| Return on equity (ROE) |
-43.1%
|
81.8%
|
11.5% |
| Change turnover |
100
|
211
|
171 |
| Change turnover % |
7%
|
16%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.